Abstract
Successful use of Eltrombopag in a patient with refractory HIV-associated Immune Thrombocytopenic Purpura
Highlights
Thrombocytopenia has been associated with Human Immunodeficiency Virus (HIV) since the beginning of the AIDS epidemic [1,2]
Two different clinical situations may be seen in HIV-associated Immune thrombocytopenia purpura (ITP): patients with advanced AIDS in which thrombocytopenia is a manifestation of bone marrow suppression and patients without significant T-cell depletion in whom thrombocytopenia develops likely as an immune phenomenon
We report our successful use of Eltrombopag in a patient with HIV-associated ITP who was refractory to standard treatments
Summary
Juárez-Salcedo LM l†*, Conde D2†, Dalia S3 1Hematology Department, Gregorio Marañón University Hospital, Madrid, Spain 2Principe de Asturias University Hospital, Madrid, Spain 3Hematology/Oncology Department, Mercy Clinic Oncology and Hematology - Joplin, Missouri, United States †Both authors contributed to this manuscript
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
